Cargando…

Anti-osteoclastic agent, denosumab, for a giant cell tumor of the bone with concurrent Paget's disease: A case report

Paget's disease of the bone may predispose the development of malignant bone tumors such as osteosarcoma. Giant cell tumor (GCT) as a consequence of Paget's disease is rare. Bone GCT is characterized by rapid growth, the destruction of bone, extension to the surrounding soft tissue and abn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Takaaki, Slavin, John, McLachlan, Sue-Anne, Choong, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403716/ https://www.ncbi.nlm.nih.gov/pubmed/28454368 http://dx.doi.org/10.3892/ol.2017.5693

Ejemplares similares

Amelioration of Paget Disease of Bone After Denosumab for Osteopenia
por: Kamalumpundi, Vijayvardhan, et al.
Publicado: (2023)

Alternative splicing in osteoclasts and Paget’s disease of bone
por: Klinck, Roscoe, et al.
Publicado: (2014)

Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
por: Upfill‐Brown, Alexander, et al.
Publicado: (2019)

Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone
por: Lipplaa, Astrid, et al.
Publicado: (2019)

Role of the Endocannabinoid/Endovanilloid System in the Modulation of Osteoclast Activity in Paget’s Disease of Bone
por: Paoletta, Marco, et al.
Publicado: (2021)

Giant-cell tumor of bone: treatment options and role of denosumab
por: Singh, Arun S, et al.
Publicado: (2015)

'Salvage Treatment' of Aggressive Giant Cell Tumor of Bones with Denosumab
por: Vaishya, Raju, et al.
Publicado: (2015)

A Recurrent Giant Cell Tumor of Bone Treated with Denosumab
por: Stadler, Nicola, et al.
Publicado: (2015)

Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
por: Egbert, Ryan Carlisle, et al.
Publicado: (2017)

Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls
por: Li, Hengyuan, et al.
Publicado: (2020)

Denosumab as a potential therapeutic option for leiomyosarcoma with osteoclast-like giant cells: A case report
por: Sasaki, Taro, et al.
Publicado: (2018)

Infiltrating giant cell tumor in a case of Paget’s disease of bone
por: Nuzzo, Vincenzo, et al.
Publicado: (2009)

Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
por: Hakozaki, Michiyuki, et al.
Publicado: (2014)

Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab
por: Mukaihara, Kenta, et al.
Publicado: (2016)

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone
por: Borkowska, Aneta, et al.
Publicado: (2016)

The Paget's disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorption
por: Wani, Sachin, et al.
Publicado: (2022)

Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
por: Kim, Albert S., et al.
Publicado: (2022)

PSAT197 Treatment of Paget's Disease of the Skull With Denosumab: A Case Report
por: Torfah, Maisoon, et al.
Publicado: (2022)

The distinct clinical features of giant cell tumor of bone in pagetic and non-pagetic patients are associated with genetic, biochemical and histological differences
por: Divisato, Giuseppina, et al.
Publicado: (2017)

Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease
por: Nagata, Yuki, et al.
Publicado: (2020)

Radiological findings of denosumab treatment for giant cell tumours of bone
por: van Langevelde, Kirsten, et al.
Publicado: (2020)

Two Cases of Sarcoma Arising in Giant Cell Tumor of Bone Treated with Denosumab
por: Broehm, Cory Julian, et al.
Publicado: (2015)

Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
por: Gaston, Czar Louie, et al.
Publicado: (2016)

Safety and efficacy of denosumab in the treatment of pulmonary metastatic giant cell tumor of bone
por: Luo, Yi, et al.
Publicado: (2018)

Giant Cell Tumors of the Bone: Changes in Image Features after Denosumab Administration
por: Oguro, Sota, et al.
Publicado: (2018)

Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab
por: Chinder, Pramod Shekarappa, et al.
Publicado: (2019)

Study of imaging changes following preoperative denosumab for giant cell tumor of bone
por: Yang, Yongkun, et al.
Publicado: (2021)

Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy
por: Xiang, Feifan, et al.
Publicado: (2022)

Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case
por: Haefliger, Simon, et al.
Publicado: (2023)

ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor
por: Divisato, Giuseppina, et al.
Publicado: (2016)

Denosumab-Treated Giant Cell Tumor of the Bone Mimicking Low-Grade Central Osteosarcoma
por: Wu, Chang-Che, et al.
Publicado: (2018)

Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
por: Engellau, Jacob, et al.
Publicado: (2018)

Short‐term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone
por: Zhang, Run‐zi, et al.
Publicado: (2019)

Giant Cell Tumor of Bone: Effect of Longer Dosing Intervals of Denosumab on Tumor Control and Bone-related Complications
por: Jiang, Cindy Y, et al.
Publicado: (2022)

Spondylectomy for Giant Cell Tumor After Denosumab Therapy
por: de Carvalho Cavalcante, Rodrigo Alves, et al.
Publicado: (2016)

Giant Cell Tumor Developing in Paget’s Disease of Bone: A Case Report with Review of Literature
por: Verma, Vivek, et al.
Publicado: (2016)

Mutations in Profilin 1 Cause Early‐Onset Paget's Disease of Bone With Giant Cell Tumors
por: Wei, Zhe, et al.
Publicado: (2021)

Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
por: Müller, Daniel A., et al.
Publicado: (2016)

Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
por: Palmerini, Emanuela, et al.
Publicado: (2021)

Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study
por: Lipplaa, Astrid, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pmf5oc55ac492lrnabmgd5ahnl